e-Therapeutics has appointed Dr. Raymond Barlow as chief executive.
He will take up the role on or before 1 May, at which point he will be appointed to the e-Therapeutics board.
Barlow, aged 48, is currently executive director of corporate development at Amgen Inc. based in Switzerland.
He brings to e-Therapeutics broad experience of drug discovery, development and commercialisation, acquired through regional and global roles in the biotech and pharmaceutical sector. His previous responsibilities have included scientific, business and corporate roles with Astra Zeneca, Crucell and Johnson and Johnson. He will be relocating to Oxford.